US Stock MarketDetailed Quotes

SCPH scPharmaceuticals

Watchlist
  • 4.840
  • -0.080-1.63%
Close Jul 24 16:00 ET
  • 4.580
  • -0.260-5.37%
Post 19:10 ET
174.50MMarket Cap-3270P/E (TTM)

scPharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

scPharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 14, 2024

Revenue(YoY)

6.10M

+195.78%
EPS(YoY)

-0.36

-20.00%
Analyst Rating

Strong Buy

Jul 24, 2024

scPharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.799M--
--2024/Q2-- / 8.086M--
May 14, 20242024/Q16.102M / 5.977M--
Mar 13, 20242023/Q46.096M / 5.771M--
Nov 8, 20232023/Q33.796M / 3.420M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.799M--
--2024/Q2-- / 8.086M--
May 14, 20242024/Q16.102M / 5.977M--
Mar 13, 20242023/Q46.096M / 5.771M--
Nov 8, 20232023/Q33.796M / 3.420M--

Unlock Free Earnings Estimates

scPharmaceuticals Earnings Reports

  • scPharmaceuticals | 10-Q: Quarterly report

    May 14 16:26 ET

  • scPharmaceuticals | 10-K: Annual report

    Mar 13 16:21 ET

  • scPharmaceuticals: Q3 2023 Earnings Report

    Nov 8, 2023 16:23 ET

  • scPharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 16:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 24, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg